Clinical Trial Detail

NCT ID NCT01841333
Title PF-04449913 For Patients With Acute Leukemia at High Risk of Relapse After Donor Stem Cell Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Glasdegib

Age Groups: adult

No variant requirements are available.